Alkem Laboratories Limited
ALKEM
Rank in Stocks
#2830
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Share Price
$55.19
Market Cap
$6.60B
Change (1 day)
-0.06%
Change (1 year)
-12.43%
Country
IN
Trade Alkem Laboratories Limited (ALKEM)
Category
Healthcare
Earnings for Alkem Laboratories Limited (ALKEM)
Earnings in Jun 2026 TTM: $316.88M
According to Alkem Laboratories Limited latest financial reports the company's current earnings are $316.88M. In 2024 the company made an earning of $242.63M, an increase over its 2023 earnings that were of $158.77M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Alkem Laboratories Limited from 2010 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $316.88M | 7.25% |
| 2025 | $295.47M | 21.78% |
| 2024 | $242.63M | 52.82% |
| 2023 | $158.77M | -34.65% |
| 2022 | $242.96M | -3.45% |
| 2021 | $251.64M | 50.48% |
| 2020 | $167.23M | 21.64% |
| 2019 | $137.48M | -3.33% |
| 2018 | $142.22M | -4.39% |
| 2017 | $148.75M | 6.15% |
| 2016 | $140.14M | 93.97% |
| 2015 | $72.25M | -3.44% |
| 2014 | $74.83M | -20.27% |
| 2013 | $93.85M | 4.73% |
| 2012 | $89.61M | 12.42% |
| 2011 | $79.71M | 46.07% |
| 2010 | $54.57M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 456.85% |
IN
|
